v3 Template
S

Swixx BioPharma AG

Healthcare & Life Sciences ~1K employees
Founded
--
Employees (Est.)
~1K
57 leaders known
Total Funding
$1.6B
Funding Rounds
1
Last Funding
2025-12-15

About Swixx BioPharma AG

Swixx BioPharma is a company dedicated to replacing biopharma, OTC, and medical device multinationals' subsidiaries in regions or therapeutic areas they choose not to enter or exit. Operating in 45 countries across Central & Eastern Europe, Middle East, Latin America, and CIS/Eurasia, Swixx aims to provide access to innovative, evidence-based medical treatments. Their mission is to partner with global healthcare companies to bring breakthrough treatments to patients, improving health outcomes and creating healthier futures for all.

Products & Services

Biopharma Services:Comprehensive market access and distribution services for biopharma companies in regions they do not directly operate, covering Central & Eastern Europe, MENAT, Latin America, and CIS/Eurasia.
Therapeutic Area Solutions:Support for partners in various therapeutic areas, including rare diseases, hemato-oncology, specialty care, and vaccines, through partnerships with leading healthcare companies.

Specialties

Biopharma Market Access Rare Diseases Hemato-Oncology Specialty Care Vaccines Pharmaceutical Distribution

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity Investment
T: -
FT: Equity Investment
A: 1650000000
MR: -
FA: in excess of EUR €1.5 billion
FAN: 1650000000
D: 2025-12-15
FD: 2025-12-15
3 investors
Equity Investment Latest
2025-12-15
$1.6B
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Petr Němec

Founder, Strategy

S

Stuart Swanson

Chairman, Founder, Head of Corporate Development

B

Barbara Košir

NED, Board Member, Ethics & Compliance Committee Chair and Audit Committee Chair

M

Matthias Fehr

Board Member and Member Audit Committee

A

Alexander Asam

Board Observer

J

Jean-François Billet

Board Member

View 54 more team members with Pro

Unlock Full Team Directory

Recent News

Swixx BioPharma AG Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare & Life Sciences
Company Size
~1K employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro